ArticleJTO clinical and research reports2024
Intracranial Response to Selpercatinib After Pralsetinib-Induced Disease Progression in Rearranged During Transfection Fusion-Positive Non-Small-Cell Lung Cancer: Case Report.
Illaa Smesseim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.